CPEB4 and central nervous system cancer: The positive expression of CPEB4 was examined in 203/228 (89.04%) of gliomas in the examined cohort (1 case of WHO II was dropped from the TMA analysis), and we confirmed no or extremely weak CPEB4 expression in 2/41 (4.88%) normal brain tissue samples (Figure 2 and Table 2).